Clinical Trials in Houston

Showing 10601-10620 of 15,366 trials

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

NCT01438554

The purpose of this study is to determine the safety and toxicity of the combination of pazopanib and GSK1120212 in patients with solid tumors and identify the maximum tolerated dose (MTD) of this combination for phase II study.

Solid TumorsThyroid CancerSoft-tissue Sarcoma+1 more

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins89 participantsStarted Oct 2011

Baltimore, Maryland, United States • Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

An Open-label Phase II Study of Lorvotuzumab Mertansine

NCT02420873

The goal of this clinical research study is to learn if lorvotuzumab mertansine can help to control blood cancers that have the CD56 tumor marker. The safety of this drug will also be studied.

Leukemia

M.D. Anderson Cancer Center9 participantsStarted May 2015

Houston, Texas, United States

UNKNOWNNA< 1 mile

Federal Evaluation of Selected Programs for Expectant and Parenting Youth

NCT03419728

Under contract to the U.S. Department of Health and Human Services (DHHS), Mathematica Policy Research is conducting an impact study of Healthy Families Healthy Futures in Houston, Texas for a Federal Evaluation of Programs for Expectant and Parenting Youth (PEPY). The impact study will be designed to address three main questions: * Was the program successful in exposing participants to program content, such as information about methods of birth control? * Was the program successful at improving short-term outcomes, such as use of a LARC and intention to space births? * To what extent did treatment youth receive the intended program components?

Teen Pregnancy PreventionContraceptive Usage

Mathematica Policy Research, Inc.248 participantsStarted Jun 2015

Houston, Texas, United States

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

An Open-label Phase II Study of Lorvotuzumab Mertansine

Federal Evaluation of Selected Programs for Expectant and Parenting Youth

Find Trials by Condition in Houston

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

Evidence Amyloid Scan EEG Study

Study of LBH589 for Patients With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Tranexamic Acid in Adherent Placenta (TAP)

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine

Intervention to Improve Follow-up of Abnormal Pap Test

A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Lutronic Infini and LaseMD Systems in Combination Treatment

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

EndovascuLar RegIstry Evaluating SafeTy, Efficacy and Patient Comfort (ELITE)

A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.

Caring Letters for Military Suicide Prevention